UK Wearable Cardiac Devices Market Analysis And Forecast To 2032: By Device (Holter Monitors, Patches, Defibrillators, Smartwatches, Others), Application (Home Healthcare, Remote Patient Monitoring, Sports and Fitness, Others), End-use (Hospitals, Home Ca

UK Wearable Cardiac Devices Market Analysis And Forecast To 2032: By Device (Holter Monitors, Patches, Defibrillators, Smartwatches, Others), Application (Home Healthcare, Remote Patient Monitoring, Sports and Fitness, Others), End-use (Hospitals, Home Care Settings, Clinics, Others), and Country

The UK Wearable Cardiac Devices market size was USD 551.6 million in 2022 and is anticipated to reach USD 3,427.6 million by 2032, growing at a rate of 19.4% from 2023 to 2032.

Wearable cardiac devices are intended to assist those with heart rhythm abnormalities in managing irregular heartbeats. The heart's electrical system, which instructs the heart to contract and circulate blood throughout the body, is the source of these anomalies. Wearable technology is a creative answer to several problems in the healthcare sector. Additionally, employed to manage patients and diseases, wearable technology has the potential to influence clinical judgment significantly. Heart-related information may be calculated, displayed, and stored in real-time using wearable cardiac devices and medical gadgets worn on the body. These items include wristwatches, patches, and fitness trackers.
UK Wearable Cardiac Devices Market Scope and Report Structure
[table id=854 /]
Market Trends and Drivers
Rising cases of cardiovascular disorders in the UK

The rising cases of cardiovascular disorders in the UK have indeed been a major concern in recent years. Around 1.2 million people in the UK are registered with atrial fibrillation, with nearly half a million (422,600) predicted to have AF undiagnosed, according to Public Health England. And there are more than 100,000 strokes in the UK each year, causing 38,000 deaths, making it a leading cause of death and disability. These numbers highlight the scale of the problem and the need for effective prevention and management strategies. This alarming trend has put significant pressure on healthcare systems and has led to an increased focus on preventive care and monitoring. In response to this growth need, propelling the demand for wearable cardiac devices in the country.

Several factors contribute to the rising cases of cardiovascular disorders in the UK. One of the key drivers is an aging population. The UK has witnessed a steady increase in the average age of its citizens, and older adults are more susceptible to heart-related problems. Additionally, unhealthy lifestyle choices such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption are major risk factors for cardiovascular diseases. The prevalence of these risk factors in the population, coupled with the high-stress levels of modern life, contribute to the increasing burden of heart diseases.
Market Restraints and Challenges
The high cost associated with wearable cardiac devices

The high cost associated with wearable cardiac devices in the UK is a significant factor restraining the growth of the market. These devices, which include wearable heart monitors, implantable cardioverter-defibrillators (ICDs), and cardiac rhythm management (CRM) devices, often come with a hefty price tag. The cost of development, manufacturing, regulatory compliance, and ongoing support services contribute to the overall expenses associated with these devices. As a result, the high prices pose a financial burden for patients, healthcare providers, and the National Health Service (NHS) in the UK, limiting the adoption and market growth of wearable cardiac devices.

One of the main reasons for the high cost of wearable cardiac devices is the research and development investment required to bring innovative technologies to market. Developing advanced sensors, miniaturized components, and reliable connectivity features involves substantial financial resources. Additionally, ensuring compliance with strict regulatory standards, such as obtaining necessary certifications, further adds to the expenses. The costs associated with clinical trials, testing, and obtaining regulatory approvals also contribute to the high price point of these devices, making them less accessible to a larger population.
UK Wearable Cardiac Devices Market Segmental Overview


The report analyses the UK Wearable Cardiac Devices Market based on device, application, end-user, and country

UK Wearable Cardiac Devices Market by Device



By Device, the UK Wearable Cardiac Devices market is bifurcated into Holter monitors, patches, defibrillators, smartwatches, and others. The Holter Monitors segment is anticipated to grow at a rate of 20.5% during the forecast period. The Holter monitoring electrocardiogram records the heart rhythm for up to a few minutes whereas Holter monitoring records the rhythm for 24 hours. This helps to detect arrhythmias that may only occur at certain times. The growth of the Holter ECG monitoring segment is driven by a rise in the geriatric population, an increase in the prevalence of heart stroke, a surge in the number of patients suffering from hypertension, and an upsurge in the prevalence of obesity. Moreover, technological advancements and growth in awareness about the feasible use of these devices are other factors that contribute to the growth of the market. However, a lack of trained professionals, inappropriate healthcare infrastructure, and unsteady reimbursement policies are expected to hinder market growth. Conversely, advanced Holter monitors with enhanced sensitive algorithms for the automatic detection of arrhythmias offer lucrative growth opportunities for the market.

UK Wearable Cardiac Devices Market by Application



Based on Application, the UK Wearable Cardiac Devices market is segmented into home healthcare, remote patient monitoring, sports and fitness, and others. The UK wearable cardiac devices market size for the home healthcare segment grew at a rate of 20.4% from 2023 to 2032. The aging population's growing desire for at-home healthcare segment will increase demand for wearable cardiac devices in the UK. It is driven mostly by the growing number of older adults with cardiovascular diseases. Additionally, wearable trackers offer effective heart rate monitoring and give users access to real-time data that assists in risk identification and lowers hospital visits. Wearable technology that continuously monitors heart problems at home will result in fewer hospital visits, increasing its popularity throughout the projection period. These technologies, designed to assist patients in their homes, allow people to get healthcare services without traveling to Hospitals or clinics. The home healthcare application includes equipment for respiratory treatment. The increased need for customized healthcare services and the aging population drives the demand for wearable medical equipment. IoT and AI technologies would also hasten the market's growth for wearable home healthcare devices.

UK Wearable Cardiac Devices Market by End-user



Based on End-user, the market is segmented into Hospitals, Retail Pharmacies, Academic Institutes, and Others. Out of these home care settings segment held the majority of the market share throughout the study period. Home care may be the answer to having the best quality of life possible. Through treatment provided in the security and comfort of home, it may facilitate safety, security, and enhanced independence; it can simplify the management of a continuing medical condition; it can assist in preventing needless hospitalization; and it can speed up recovery after an illness, accident, or hospital stay. Even when frailty is a problem, in-home care often results in better life satisfaction. Home care aids and preserves family unity. Families typically take a more active role in providing care and fostering close relationships with their loved ones. Home care professionals have developed effective models for illness management, medication management, behavioral education, and care coordination in recent years. They have set the bar for creative and economic applications of treatments and technology to provide high-quality, client-centered care throughout the healthcare delivery system.
Country Analysis of UK Wearable Cardiac Devices Market


The wearable cardiac devices market, based on country is segmented into England, Wales, Scotland, and Ireland. Among these, England is anticipated to grow at a CAGR of 19.0% from 2023 to 2032.. The number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other conditions of the heart patients in England is substantial. In accordance with the British Heart Foundation (BHF), there are over 7 million individuals living with CVD, and around 152,465 deaths are related to CVD. Critical risk factors for CVD, CHD, Stroke, and other heart diseases include detrimental stress, depression, excessive alcohol use, excessive smoking, high blood pressure, diabetes, obesity, and a poor diet that contains cholesterol. As a result, people were encouraged to prioritize preventative healthcare, which implies that people are spending a lot of money on smart wearable healthcare gadgets. This will fuel the expansion of wearable cardiac device industry.
Major Players in theUK Wearable Cardiac Devices Market
The key players in the UK Wearable Cardiac Devices Market are Boston Scientific Corporation, iRhythm Technologies, Inc., Asahi Kasei Corporation (ZOLL Medical Corporation), Qardio, Inc., Otsuka Holdings Co., Ltd. (Proteus Digital Health), CONMED Corporation, Sky Labs, MedtronicSAMSUNG, Baxter (Welch Allyn), Fitbit Inc., Apple Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CardioScan, CardioSTAT (Icentia Inc.), and Koninklijke Philips N.V., among others.
COVID-19 Impact:
Increasing cases of coronavirus-infected patients are predicted to drive the UK wearable cardiac devices market. Most organizations focus on various initiatives to provide solutions to cardiovascular disease across the UK. The COVID-19 pandemic has sped up the creation of health and fitness apps by incorporating artificial intelligence (AI) technology with conventional healthcare. Users are taking infection prevention measures with wearable technology thanks to COVID-19's improved awareness of personal cleanliness. For instance, Apple added new sleeping beats per minute (BPM) option to the Cardiogram app, which records users' heart rates, to track heart rate swings in those using COVID-19.

Further, due to the exploited healthcare systems during the pandemic, millions may have a higher risk of infections. Therefore, most manufacturers are focusing more on building new products so that cardiovascular disease patients are not required to visit Hospitals frequently. Thus, the COVID-19 pandemic had a positive impact on the market.
Recent Developments:

In December 20222, Mindray introduces new wearable patient monitoring system, refining clinicia’s workflow to track patient conditions. “mWearTM” supports comprehensive and precise measurements of patient status, integrating 6 key vital signs powered by Anti-motion Algorithm, specialized health parameters, status indicators and time analysis. mWearTM features two monitoring modes, Wearable Mode and Continuous Mode, for caregivers to get patient status updates accordingly to the customize setting, and intelligently triggers emergencies and alarm escalations to ensure timely response to patient deterioration.
In September 2022, Apple introduced Apple Watch Series 8 and the new Apple Watch SE, which bring ground breaking technology and performance, and important safety innovations to the two best-selling smartwatches. The new Apple Watch SE delivers the core Apple Watch experience, including Activity tracking, high and low heart rate notifications, and Emergency SOS, as well as the new Crash Detection feature.
In August 2022, Medtronic plc announced the completion of its acquisition of Affera, Inc. This purchase broadens the company's cardiac ablation offering by adding its inaugural cardiac mapping and navigation platform, which includes a distinct, fully integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.

UK Wearable Cardiac Devices Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current UK Wearable Cardiac Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
 The report also covers qualitative as well as quantitative analysis of UK Wearable Cardiac Devices Market in terms of revenue ($Million)
 Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the UK Wearable Cardiac Devices industry.
 A thorough analysis of market trends and restraints is provided.
By country as well as country market analysis is also presented in this report.
 Analytical depiction of the UK Wearable Cardiac Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall UK Wearable Cardiac Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
 Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the UK Wearable Cardiac Devices Market are also analyzed.

Frequently Asked Questions
Q1. How big is the UK Wearable Cardiac Devices Market?

Ans. The UK Wearable Cardiac Devices market size was USD 551.6 million in 2022 and is anticipated to reach USD 3,427.6 million by 2032, growing at a rate of 19.4% from 2023 to 2032.

Q2. What is the UK Wearable Cardiac Devices Market growth rate?

Ans. The growth rate of the UK Wearable Cardiac Devices market is 19.4%

Q3. Which country holds a major market share for the market?

Ans. England holds a major market share of the UK Wearable Cardiac Devices Market in 2022.

Q4. Which segment accounted for the largest UK Wearable Cardiac Devices Market share?

Ans. By application, segment accounted for the largest UK Wearable Cardiac Devices Market share.

Q5. Who are the key players in the kidney stones management market?

Ans. The UK Wearable Cardiac Devices Market report includes players such  Boston Scientific Corporation, iRhythm Technologies, Inc., Asahi Kasei Corporation (ZOLL Medical Corporation), Qardio, Inc., Otsuka Holdings Co., Ltd. (Proteus Digital Health), CONMED Corporation, Sky Labs, MedtronicSAMSUNG, Baxter (Welch Allyn), Fitbit Inc., Apple Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CardioScan, CardioSTAT (Icentia Inc.), and Koninklijke Philips N.V., among others.

Q6. What are the factors driving the UK Wearable Cardiac Devices Market growth?

Ans. The major factors driving the growth of the market are growing concern related to health.

Q7. What are the key growth strategies of UK Wearable Cardiac Devices Market players?

Ans. The key growth strategies of UK Wearable Cardiac Devices Market players are product launch and product approval.

Q8. Which country will provide more business opportunities for the UK Wearable Cardiac Devices Market during the forecast period?

Ans. The Aegland  will provide more business opportunities for the UK Wearable Cardiac Devices Market during the forecast period.



*Please Note: The report will be delivered in 3-4 business days upon order confirmation*